72 results
Page 2 of 4
6-K
EX-99.1
pebhm8xf
11 Aug 20
Aurinia Pharmaceuticals Inc. 6-K
4:02pm
6-K
EX-99.3
m4t6d6a8z010m59ufn
28 Apr 20
Notice of Annual General and Special Meeting of Shareholders
4:30pm
6-K
EX-99.1
ntlxo7jq
20 Apr 20
Aurinia Pharmaceuticals Inc. 6-K
9:00am
6-K
EX-99.1
fevqzdahabpwqt d4
17 Mar 20
Aurinia Pharmaceuticals Inc. 6-K
5:05pm
40-F
EX-99.1
x53tuvly4ym 6d471usp
5 Mar 20
Annual report (Canada)
4:06pm
40-F
EX-99.3
tpsl40qje701mi02ygg
5 Mar 20
Annual report (Canada)
4:06pm
6-K
imlij
25 Feb 20
Aurinia Pharmaceuticals Inc. 6-K
6:30am
6-K
EX-99.1
uw76k3kpvjcttnpbbt9
25 Feb 20
Aurinia Pharmaceuticals Inc. 6-K
6:30am
6-K
EX-99.2
f3qjcnr
14 Nov 19
Current report (foreign)
4:05pm
6-K
EX-99.3
q3oj3 8alv3
6 Aug 19
Current report (foreign)
4:06pm
6-K
EX-99.1
4u97gx588q pfmdzhv8
18 Jul 19
Aurinia Pharmaceuticals Inc. 6-K
6:30am
6-K
EX-99.2
cjxjrqod
31 May 19
Notice of Annual General Meeting of Shareholders
8:26am
6-K
EX-99.4
056vlrylv 2m8ukd8klj
31 May 19
Notice of Annual General Meeting of Shareholders
8:26am
40-F
EX-99.1
p6b7 6a1u4l79u
19 Mar 19
Annual report (Canada)
4:16pm
6-K
EX-99.1
51rmzvp1
8 Nov 18
Aurinia Reports Third Quarter Financial Results, Clinical Highlights and Corporate Development
4:02pm
6-K/A
EX-99.3
8bzqbb1hbmxa6w oegl
17 May 18
Current report (foreign) (amended)
12:00am
6-K
EX-99.1
xs6tc
20 Oct 17
Aurinia to Expand Renal Franchise with Novel Indications and Launches Development Program for Treatment of Dry Eye Syndrome
12:00am
40FR12B/A
EX-99.27
r3p h053lnv
19 Jun 14
Initial registration of securities (Canada) (amended)
12:00am
40FR12B/A
EX-99.56
w1hppyel
19 Jun 14
Initial registration of securities (Canada) (amended)
12:00am
40FR12B/A
EX-99.44
eo2b9
19 Jun 14
Initial registration of securities (Canada) (amended)
12:00am